Salivary metabolite signatures of oral cancer and leukoplakia

International Journal of Cancer

Volumn 129, Issue 9, 2011, Pages 2207-2217

  Wei, Jie ^a   Xie, Guoxiang ^b   Zhou, Zengtong ^a   Shi, Peng ^a   Qiu, Yunping ^b   Zheng, Xiaojiao ^a   Chen, Tianlu ^c   Su, Mingming ^d   Zhao, Aihua ^a   Jia, Wei ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Shanghai Jiao Tong University   (China)

^d David H Murdock Research Institute   (United States)

Author keywords

metabolomics; multivariate statistical analysis; oral squamous cell carcinoma; receiver operating characteristics; saliva; ultraperformance liquid chromatography quadrupole time of flight mass spectrometry

Indexed keywords

4 AMINOBUTYRIC ACID; ARACHIDIC ACID; LACTIC ACID; PHENYLALANINE; VALINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; METABOLOME; METABOLOMICS; MOUTH CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RECEIVER OPERATING CHARACTERISTIC; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADULT; AGED; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; ROC CURVE; SALIVA; TUMOR MARKERS, BIOLOGICAL;

EID: 80052272696     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25881     Document Type: Article

References (48)

1. American Cancer Society. Cancer facts and figures 2009. Atlanta: American Cancer Society, 2009.
2. Epstein JB, Zhang L, Rosin M,. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002; 68: 617-21.
3. Mao L, Hong WK, Papadimitrakopoulou VA,. Focus on head and neck cancer. Cancer Cell 2004; 5: 311-6. (Pubitemid 38482067)
4. Myers JN, Elkins T, Roberts D, Byers RM,. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122: 44-51. (Pubitemid 30051688)
5. Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, Salo T,. Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-19. (Pubitemid 30636302)
6. Ribeiro KC, Kowalski L, Latorre MR,. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000; 126: 1079-85.
7. Scully C, Felix DH,. Oral Medicine-update for the dental practitioner-oral cancer. Br Dent J 2006; 200: 13-17. (Pubitemid 43128189)
8. Wong DT,. Towards a simple, saliva-based test for the detection of oral cancer. Expert Rev Mol Diagn 2006; 6: 267-72.
9. Xu GQ, Li BQ, Li HH, eds. Oral precancerous pathological changes-oral leukoplakia and oral lichen planus, 1st edn., Beijing: Chinese Medical Science and Technology Publishing House, 1992. 67 p.
10. Li Y, Zhou X, St. John MA, Wong DT,. RNA profiling of cell-free saliva using microarray technology. J Dent Res 2004; 83: 199-203. (Pubitemid 41715238)
11. Hu S, Arellano M, Boontheung P, Wang JH, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT,. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008; 14: 6246-52.
12. Li Y, St. John MAR, Zhou XF, Kim Y, Sinha U, Jordan RCK, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT,. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004; 10: 8442-50. (Pubitemid 40053408)
13. Li Y, Elashoff D, Oh M, Sinha U, St. John MAR, Zhou XF, Abemayor E, Wong DT,. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 2006; 24: 1754-60. (Pubitemid 46622147)
14. Nagler R, Bahar G, Shpitzer T, Feinmesser R,. Concomitant analysis of salivary tumor markers-A new diagnostic tool for oral cancer. Clin Cancer Res 2006; 12: 3979-84. (Pubitemid 44078083)
15. Dr. David T., Wong and the UCLA Dental Research Institute. Saliva-Based Translational Research & Clinical Applications (StarCA), Los Angeles, 2007.
16. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M,. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010; 6: 78-95.
17. Yan SK, Wei BJ, Lin ZY, Yang Y, Zhou ZT, Zhang WD,. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol 2008; 44: 477-83. (Pubitemid 351608618)
18. Dunn WB, Bailey NJ, Johnson HE,. Measuring the metabolome: current analytical technologies. Analyst 2005; 130: 606-25. (Pubitemid 40685888)
19. Qiu Y, Cai G, Su M, Chen T, Zheng X, Cai S, Ni Y, Zhao A, Xu LX, Xu Y, Jia W,. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 2009; 8: 4844-50.
20. Zhou JL, Xu B, Huang J, Jia XM, Xue J, Shi XC, Xiao LY, Li W,. H-1 NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. Clin Chim Acta 2009; 401: 8-13.
21. Nicholson JK, Lindon J, Holmes E,. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-89.
22. Fiehn O,. Combining genomics metabolome analysis and biochemical modeling to understand metabolic networks. Comp Funct Genomics 2001; 2: 155-68. (Pubitemid 32590962)
23. Stitt M,., Fernie AR,. From measurements of metabolites to metabolomics: an 'on the fly' perspective illustrated by recent studies of carbon-nitrogen interactions. Curr Opin Biotechnol 2003; 14: 136-44. (Pubitemid 36561226)
24. Tiziani S, Lopes V, Gunther UL,. Early stage diagnosis of oral cancer using H-1 NMR-based metabolomics. Neoplasia 2009; 11: 269-76.
25. Navazesh M,. Methods for collecting saliva. Ann NY Acad Sci 1993; 694: 72-77. (Pubitemid 23298232)
26. Xie GX, Ni Y, Su MM, Zhang YY, Zhao AH, Gao XF, Liu Z, Xiao PG, Jia W,. Application of ultra-performance LC-TOF MS metabolite profiling techniques to the analysis of medicinal Panax herbs. Metabolomics 2008; 4: 248-60.
27. Ni Y, Su M, Qiu Y, Chen M, Liu Y, Zhao A, Jia W,. Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat. FEBS Lett 2007; 581: 707-11. (Pubitemid 46216297)
28. Trygg J, Wold S,. Orthogonal projections to latent structures (O-PLS). J Chemometrics 2002; 16: 119-28.
29. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, Lindon JC, Nicholson JK, Holmes E,. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem 2005; 77: 517-26. (Pubitemid 40116831)
30. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P,. Metabolomics reveals metabolic biomarkers of Crohn's disease. Plos One 2009; 4: e6368.
31. Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz T, Trygg J,. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 2008; 80: 115-22. (Pubitemid 351448411)
32. Ni Y, Su MM, Lin JC, Wang XY, Qiu YP, Zhao AH, Chen TL, Jia W,. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Lett 2008; 582: 2627-36.
33. Benjamini Y, Hochberg Y,. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995; 57: 289-300.
34. Storey JD,. A direct approach to false discovery rates. J Roy Statist Soc Ser B 2002; 64: 479-98.
35. Qiu YP, Cai GX, Su MM, Chen TL, Liu YM, Xu Y, Ni Y, Zhao AH, Cai SJ, Xu LX, Jia W,. Urinary metabonomic study on colorectal cancer. J Proteome Res 2010; 9: 1627-34.
36. Gatenby RA, Gillies RJ,. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-99. (Pubitemid 39472955)
37. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-42.
38. Gibala MJ,. Regulation of skeletal muscle amino acid metabolism during exercise. Int J Sport Nutr Exerc Metab 2001; 11: 87-108.
39. Cole JT, Mitala CM, Kundu S, Verma A, Elkind JA, Nissim I, Cohen AS,. Dietary branched chain amino acids ameliorate injury-induced cognitive impairment. Proc Natl Acad Sci USA 2010; 107: 366-71.
40. Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, Ofrecio JM, Chapman J, Subramaniam S,. Mechanisms of human insulin resistance and thiazolidinedione- mediated insulin sensitization. Proc Natl Acad Sci USA 2009; 106: 18745-50.
41. Bojan O, Mustea I, Preda N,. Changes of some free amino acid levels in sera of cancer patients. Influence of glucose on tumoral metabolism. Clin Chim Acta 1969; 23: 335-38.
42. Baracos VE, Mackenzie ML,. Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr 2006; 136: 237S-42S. (Pubitemid 43156516)
43. Young SZ, Bordey A,. GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology 2009; 24: 171-85
44. Schuller HM, Al-Wadei HAN, Majidi M,. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 2008; 29: 1979-85.
45. Joseph J, Niggemann B, Zaenker KS, Entschladen F,. The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res 2002; 62: 6467-69. (Pubitemid 35364108)
46. Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, Sperner-Unterweger B, Fuchs D,. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Lett 2008; 272: 141-47.
47. Chan ECY, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC,. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 2009; 8: 352-61.
48. Toporcov TN, Antunes JLF, Tavares MR,. Fat food habitual intake and risk of oral cancer. Oral Oncol 2004; 40: 925-31. (Pubitemid 39369565)